Shobana Sampath | Drug Formulation | Editorial Board Member

Published on by Biotechnology Scientist

Assist. Prof. Dr. Shobana Sampath | Drug Formulation | Editorial Board Member

Assistant Professor at Vel Tech Rangarajan Dr.Sagunthala R&D Institute of Science and Technology | India

Assist. Prof. Dr. Shobana Sampath is an accomplished biotechnology researcher specializing in nanobiotechnology, cancer biology, immunology, and therapeutic nanoformulation, focusing on the development of biocompatible nanoparticles through green synthesis for disease mitigation. She has applied her research across antibacterial, antioxidant, anticancer, and antidiabetic applications using both cellular and molecular level analyses. Her Ph.D. work demonstrated novel biological applications of silver and zinc oxide nanoparticles, including mechanisms of apoptosis, cell-cycle arrest, and reactive oxygen species regulation in cancer systems, supported by toxicity-free validation in animal models. With a strong record of scientific publishing, she has produced 40 Scopus-indexed documents, 354 citations, and holds a Scopus h-index of 11. Her publications include high-impact SCI journals, addressing nanoparticles for targeted therapy, nanocomposite-based antimicrobial applications, eco-nanotechnology for sustainable health, and advanced biomaterials for aquaculture and regenerative medicine. She also contributes significantly to scholarly discourse as a reviewer for multiple international journals and as a Special Issue Editor for MDPI Sustainability (Q2), strengthening the scientific quality control ecosystem. Her authored and ongoing book chapters with renowned publishers such as Wiley, Springer Nature, and Elsevier-aligned imprints explore nanotechnology innovations for health, agriculture, and environmental sustainability. Actively engaged in academic leadership and research supervision, she continues to support translational outcomes in biotechnology, positioning her as a valuable contributor to global biomedical research and well-qualified for Editorial Board leadership roles.

Profiles : Scopus | ORCID | Google Scholar

Featured Publications

Sampath, S., Madhavan, Y., Muralidharan, M., Sunderam, V., & Lawrance, A. V. (2022). A review on algal mediated synthesis of metal and metal oxide nanoparticles and their emerging biomedical potential. Journal of Biotechnology, 360, 92–109. Cited by: 55

Sampath, S., Sunderam, V., Manjusha, M., Dlamini, Z., & Lawrance, A. V. (2024). Selenium nanoparticles: A comprehensive examination of synthesis techniques and their diverse applications in medical research and toxicology studies. Molecules, 29(4), 801. Cited by: 54

Sampath, S., Bhushan, M., Saxena, V., Pandey, L. M., & Singh, L. R. (2022). Green synthesis of Ag doped ZnO nanoparticles: Study of their structural, optical, thermal and antibacterial properties. Materials Technology, 37(13), 2785–2794. Cited by: 38

Shobana, S., Veena, S., Sameer, S. S. M., Swarnalakshmi, K., & Lawrance, L. A. (2020). Green synthesis of silver nanoparticles using Artocarpus hirsutus seed extract and its antibacterial activity. Current Pharmaceutical Biotechnology, 21(10), 980–989. Cited by: 38

Mohammed, S. S. S., Lawrance, A. V., Sampath, S., Sunderam, V., & Madhavan, Y. (2022). Facile green synthesis of silver nanoparticles from sprouted Zingiberaceae species: Spectral characterisation and its potential biological applications. Materials Technology, 37(8), 533–546. Cited by: 34

Kwangsuk Lim | Biopharmaceuticals | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Kwangsuk Lim | Biopharmaceuticals | Best Researcher Award

Asoociate Professor at Kangwon National University | South Korea

Prof. Kwang Suk Lim, Ph.D., is an accomplished Associate Professor in the Department of Biotechnology and Bioengineering at Kangwon National University, South Korea, whose research spans biotechnology, nanomedicine, and bioengineering with a strong focus on cancer immunotherapy, targeted drug delivery, and biopolymer applications. His work emphasizes the development of recombinant fusion proteins, nanocomplexes, and chimeric antigen receptor (CAR)-based strategies for enhancing immune-cell therapeutics. He has also contributed to advancing chemo-immunotherapy platforms, surface-engineered natural killer (NK) cells, and the application of metal–organic frameworks for microplastic degradation and environmental protection. Dr. Lim’s interdisciplinary research has been published in high-impact journals such as Pharmaceutics, Biomedicine & Pharmacotherapy, and Environmental Pollution, reflecting his leadership in translational biomedical innovation. His scientific record includes 25 Scopus-indexed publications with 260 citations by 251 documents and an h-index of 9, alongside multiple Korean and international patents in biomaterials, recombinant protein therapeutics, and drug delivery technologies. He has been recognized with several honors, including the Kangwon National University Teaching Award and the Bioengineering Researcher Award, underscoring his excellence in both academic and research achievements.

Profile: Scopus | ORCID

Featured Publications

Lim, S. Y., Kim, Y., Han, S., Kim, H.-O., Ha, S.-J., Park, J.-A., Yun, J., Chae, S., Won, Y.-W., & Lim, K. S. (2025). CliCAR: A non-genetic CAR engineering strategy to empower NK cells for targeted cancer immunotherapy. Biomedicine & Pharmacotherapy, 193, 118691.

Kim, Y., Kwak, J., Lim, M., Lim, S. Y., Chae, S., Ha, S.-J., Won, Y.-W., Kim, H.-O., & Lim, K. S. (2025). Advances in PCL, PLA, and PLGA-based technologies for anticancer drug delivery. Pharmaceutics, 17, 1354.

Lim, S. Y., Kim, Y., Kim, H., Han, S., Yun, J., Kim, H.-O., Ha, S.-J., Chae, S., Won, Y.-W., & Lim, K. S. (2025). Surface engineering of natural killer cells with lipid-based antibody capture platform for targeted chemoimmunotherapy. Pharmaceutics, 17(10), 1285.

Kim, Y., Lim, S. Y., Kim, H.-O., Ha, S.-J., Park, J.-A., Won, Y.-W., Chae, S., & Lim, K. S. (2025). Combination strategies with HSP90 inhibitors in cancer therapy: Mechanisms, challenges, and future perspectives. Pharmaceuticals, 18(8), 1083.

Lim, S. Y., Han, S., Kim, Y., Kim, H., Kim, Y., Park, J.-A., Yun, J., Yong, S.-B., Won, Y.-W., & Lim, K. S. (2025). Advanced breast cancer immunotherapy: Surface modification of NK cells for embedding antibody-drug conjugates. Biomedicine & Pharmacotherapy, 189, 118245.